Cargando…
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome?
BACKGROUND: Copy number variations (CNVs) can contribute to genetic variation among individuals and/or have a significant influence in causing diseases. Many studies consider new CNVs’ effects on protein family evolution giving rise to gene duplicates or losses. “Unsuccessful” duplicates that remain...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422118/ https://www.ncbi.nlm.nih.gov/pubmed/25927938 http://dx.doi.org/10.1186/s12881-015-0164-3 |
_version_ | 1782370008276402176 |
---|---|
author | D’Apice, Maria Rosaria Novelli, Antonio di Masi, Alessandra Biancolella, Michela Antoccia, Antonio Gullotta, Francesca Licata, Norma Minella, Daniela Testa, Barbara Nardone, Anna Maria Palmieri, Giampiero Calabrese, Emma Biancone, Livia Tanzarella, Caterina Frontali, Marina Sangiuolo, Federica Novelli, Giuseppe Pallone, Francesco |
author_facet | D’Apice, Maria Rosaria Novelli, Antonio di Masi, Alessandra Biancolella, Michela Antoccia, Antonio Gullotta, Francesca Licata, Norma Minella, Daniela Testa, Barbara Nardone, Anna Maria Palmieri, Giampiero Calabrese, Emma Biancone, Livia Tanzarella, Caterina Frontali, Marina Sangiuolo, Federica Novelli, Giuseppe Pallone, Francesco |
author_sort | D’Apice, Maria Rosaria |
collection | PubMed |
description | BACKGROUND: Copy number variations (CNVs) can contribute to genetic variation among individuals and/or have a significant influence in causing diseases. Many studies consider new CNVs’ effects on protein family evolution giving rise to gene duplicates or losses. “Unsuccessful” duplicates that remain in the genome as pseudogenes often exhibit functional roles. So, changes in gene and pseudogene number may contribute to development or act as susceptibility alleles of diseases. CASE PRESENTATION: We report a de novo heterozygous 271 Kb microdeletion at 8q21.2 region which includes the family of REXO1L genes and pseudogenes in a young man affected by global development delay, progeroid signs, and gastrointestinal anomalies. Molecular and cellular analysis showed that the REXO1L1 gene hemizygosity in a patient’s fibroblasts induces genetic instability and increased apoptosis after treatment with different DNA damage-induced agents. CONCLUSIONS: The present results support the hypothesis that low copy gene number within REXO1L1 cluster could play a significant role in this complex clinical and cellular phenotype. |
format | Online Article Text |
id | pubmed-4422118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44221182015-05-07 Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? D’Apice, Maria Rosaria Novelli, Antonio di Masi, Alessandra Biancolella, Michela Antoccia, Antonio Gullotta, Francesca Licata, Norma Minella, Daniela Testa, Barbara Nardone, Anna Maria Palmieri, Giampiero Calabrese, Emma Biancone, Livia Tanzarella, Caterina Frontali, Marina Sangiuolo, Federica Novelli, Giuseppe Pallone, Francesco BMC Med Genet Case Report BACKGROUND: Copy number variations (CNVs) can contribute to genetic variation among individuals and/or have a significant influence in causing diseases. Many studies consider new CNVs’ effects on protein family evolution giving rise to gene duplicates or losses. “Unsuccessful” duplicates that remain in the genome as pseudogenes often exhibit functional roles. So, changes in gene and pseudogene number may contribute to development or act as susceptibility alleles of diseases. CASE PRESENTATION: We report a de novo heterozygous 271 Kb microdeletion at 8q21.2 region which includes the family of REXO1L genes and pseudogenes in a young man affected by global development delay, progeroid signs, and gastrointestinal anomalies. Molecular and cellular analysis showed that the REXO1L1 gene hemizygosity in a patient’s fibroblasts induces genetic instability and increased apoptosis after treatment with different DNA damage-induced agents. CONCLUSIONS: The present results support the hypothesis that low copy gene number within REXO1L1 cluster could play a significant role in this complex clinical and cellular phenotype. BioMed Central 2015-04-02 /pmc/articles/PMC4422118/ /pubmed/25927938 http://dx.doi.org/10.1186/s12881-015-0164-3 Text en © D'Apice et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report D’Apice, Maria Rosaria Novelli, Antonio di Masi, Alessandra Biancolella, Michela Antoccia, Antonio Gullotta, Francesca Licata, Norma Minella, Daniela Testa, Barbara Nardone, Anna Maria Palmieri, Giampiero Calabrese, Emma Biancone, Livia Tanzarella, Caterina Frontali, Marina Sangiuolo, Federica Novelli, Giuseppe Pallone, Francesco Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title | Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title_full | Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title_fullStr | Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title_full_unstemmed | Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title_short | Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
title_sort | deletion of rexo1l1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422118/ https://www.ncbi.nlm.nih.gov/pubmed/25927938 http://dx.doi.org/10.1186/s12881-015-0164-3 |
work_keys_str_mv | AT dapicemariarosaria deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT novelliantonio deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT dimasialessandra deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT biancolellamichela deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT antocciaantonio deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT gullottafrancesca deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT licatanorma deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT minelladaniela deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT testabarbara deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT nardoneannamaria deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT palmierigiampiero deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT calabreseemma deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT bianconelivia deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT tanzarellacaterina deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT frontalimarina deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT sangiuolofederica deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT novelligiuseppe deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome AT pallonefrancesco deletionofrexo1l1locusinapatientwithmalabsorptionsyndromegrowthretardationanddysmorphicfeaturesanovelrecognizablemicrodeletionsyndrome |